Crystallization (Comment) | Organism |
---|---|
hanging drop vapor diffusion method | Leishmania infantum |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-(4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-(2-(naphthalen-2-yl)ethyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamido)butyl)guanidinium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
4-(2-(([1,1'-biphenyl]-4-ylmethyl)amino)-N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-7Hpyrrolo[2,3-d]pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-((2-(naphthalen-2-yl)ethyl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-((3-phenylpropyl)amino)-7H-pyrrolo-[2,3-d]pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-(phenethylamino)-7H-pyrrolo[2,3-d]-pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
Mepacrine | - |
Leishmania infantum | |
N1-((1-(3-(2-(2-oxoimidazolidin-1-yl)ethoxy)-4-(4-phenethylthiazol-2-yl)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
N1-((1-(4-(4-(2-(naphthalen-2-yl)ethyl)thiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)-methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
N1-((1-(4-(4-(2-([1,1'-biphenyl]-4-yl)ethyl)thiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
N1-((1-(4-(4-benzylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
N1-((1-(4-(4-isobutylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
N1-((1-(4-(4-neopentylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | - |
Leishmania infantum | |
PKIIQSVGICMKM | - |
Leishmania infantum |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
trypanothione disulfide + NADPH + H+ | Leishmania infantum | - |
trypanothione + NADP+ | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Leishmania infantum | A4HSF7 | - |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
trypanothione disulfide + NADPH + H+ | - |
Leishmania infantum | trypanothione + NADP+ | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Li-TryR | - |
Leishmania infantum |
trypanothione reductase | - |
Leishmania infantum |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0012 | - |
pH 6.0, 26°C | Leishmania infantum | PKIIQSVGICMKM | |
0.0051 | - |
pH 6.0, 26°C | Leishmania infantum | N1-((1-(4-(4-(2-(naphthalen-2-yl)ethyl)thiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)-methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | |
0.0086 | - |
pH 6.0, 26°C | Leishmania infantum | N1-((1-(4-(4-(2-([1,1'-biphenyl]-4-yl)ethyl)thiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | |
0.0129 | - |
pH 6.0, 26°C | Leishmania infantum | Mepacrine | |
0.0224 | - |
pH 6.0, 26°C | Leishmania infantum | N1-((1-(3-(2-(2-oxoimidazolidin-1-yl)ethoxy)-4-(4-phenethylthiazol-2-yl)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | |
0.0328 | - |
pH 6.0, 26°C | Leishmania infantum | N1-((1-(4-(4-benzylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | |
0.0399 | - |
pH 6.0, 26°C | Leishmania infantum | 1-(4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-(2-(naphthalen-2-yl)ethyl)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamido)butyl)guanidinium 2,2,2-trifluoroacetate | |
0.0512 | - |
pH 6.0, 26°C | Leishmania infantum | N1-((1-(4-(4-isobutylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | |
0.0513 | - |
pH 6.0, 26°C | Leishmania infantum | N1-((1-(4-(4-neopentylthiazol-2-yl)-3-(2-(2-oxoimidazolidin-1-yl)ethoxy)phenyl)-1H-imidazol-2-yl)methyl)ethane-1,2-diaminium 2,2,2-trifluoroacetate | |
0.0517 | - |
pH 6.0, 26°C | Leishmania infantum | 4-(2-(([1,1'-biphenyl]-4-ylmethyl)amino)-N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-7Hpyrrolo[2,3-d]pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | |
0.0522 | - |
pH 6.0, 26°C | Leishmania infantum | 4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-((2-(naphthalen-2-yl)ethyl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | |
0.0946 | - |
pH 6.0, 26°C | Leishmania infantum | 4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-((3-phenylpropyl)amino)-7H-pyrrolo-[2,3-d]pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate | |
0.1002 | - |
pH 6.0, 26°C | Leishmania infantum | 4-(N-(2-amino-2-oxoethyl)-7-(3-amino-3-oxopropyl)-4-(dimethylamino)-2-(phenethylamino)-7H-pyrrolo[2,3-d]-pyrimidine-6-carboxamido)butan-1-aminium 2,2,2-trifluoroacetate |